These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22616813)

  • 1. Preclinical toxicity profile of oral bilastine.
    Lucero ML; Arteche JK; Sommer EW; Casadesus A
    Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():25-33. PubMed ID: 22616813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral availability of bilastine.
    Sádaba B; Gómez-Guiu A; Azanza JR; Ortega I; Valiente R
    Clin Drug Investig; 2013 May; 33(5):375-81. PubMed ID: 23529786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria.
    Rodríguez M; Vozmediano V; García-Bea A; Novák Z; Yáñez A; Campo C; Labeaga L
    Eur J Pediatr; 2020 May; 179(5):801-805. PubMed ID: 31919579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis.
    Tyl B; Kabbaj M; Azzam S; Sologuren A; Valiente R; Reinbolt E; Roupe K; Blanco N; Wheeler W
    J Clin Pharmacol; 2012 Jun; 52(6):893-903. PubMed ID: 21642470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilastine for the relief of allergy symptoms.
    Sádaba Díaz de Rada B; Azanza Perea JR; Gomez-Guiu Hormigos A
    Drugs Today (Barc); 2011 Apr; 47(4):251-62. PubMed ID: 21573249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.
    Jáuregui I; Ramaekers JG; Yanai K; Farré M; Redondo E; Valiente R; Labeaga L
    Expert Opin Drug Saf; 2016 Jan; 15(1):89-98. PubMed ID: 26571227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects.
    Togawa M; Yamaya H; Rodríguez M; Nagashima H
    Clin Drug Investig; 2016 Dec; 36(12):1011-1021. PubMed ID: 27498100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilastine: a new H
    Church MK; Labeaga L
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1447-1452. PubMed ID: 28467671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population.
    Vozmediano V; Lukas JC; Encinas E; Schmidt S; Sologuren A; Valiente R; Labeaga L; Campo C; Rodriguez M
    Eur J Pharm Sci; 2019 Feb; 128():180-192. PubMed ID: 30468868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A; Furue M; Togawa M; Saito A; Hide M
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of bilastine, a new oral H₁ antihistamine, with human transporter systems.
    Lucero ML; Gonzalo A; Ganza A; Leal N; Soengas I; Ioja E; Gedey S; Jahic M; Bednarczyk D
    Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():8-17. PubMed ID: 22616811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Hide M; Yagami A; Togawa M; Saito A; Furue M
    Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of bilastine metabolism during preclinical investigations.
    Lucero ML; Gonzalo A; Mumford R; Betanzos M; Alejandro A
    Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():18-24. PubMed ID: 22616812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilastine: an environmental risk assessment.
    Lucero ML; Peither A; Ledo F
    Drug Chem Toxicol; 2015 Oct; 38(4):460-8. PubMed ID: 25609003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effect of bilastine.
    Jauregizar N; de la Fuente L; Lucero ML; Sologuren A; Leal N; Rodríguez M
    Clin Pharmacokinet; 2009; 48(8):543-54. PubMed ID: 19705924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body tissue distribution of total radioactivity in rats after oral administration of [¹⁴C]-bilastine.
    Lucero ML; Patterson AB
    Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():1-7. PubMed ID: 22616810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers.
    Conen S; Theunissen EL; Van Oers AC; Valiente R; Ramaekers JG
    J Psychopharmacol; 2011 Nov; 25(11):1517-23. PubMed ID: 20855350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.